Extracorporeal magnetic innervation increases functional bladder capacity and quality of life in patients with urinary incontinence after robotic-assisted radical prostatectomy

Postprostatectomy incontinence (PPI) is a major health problem that has substantial effects on health-related quality of life. In recent years, extracorporeal magnetic innervation (ExMI) has become a preferred treatment method for urinary incontinence. We evaluated the effects of ExMI on patients wi...

Full description

Saved in:
Bibliographic Details
Published in:Urological science 2015-12, Vol.26 (4), p.250-253
Main Authors: Chang, Po-Chih, Wu, Chun-Te, Huang, Shih-Tsung, Chen, Yu, Huang, Hsin-Chieh, Hsu, Yu-Chao, Hsieh, Ming-Li
Format: Article
Language:English
Subjects:
extracorporeal magnetic innervation
quality of life
robotic-assisted radical prostatectomy
urinary incontinence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Postprostatectomy incontinence (PPI) is a major health problem that has substantial effects on health-related quality of life. In recent years, extracorporeal magnetic innervation (ExMI) has become a preferred treatment method for urinary incontinence. We evaluated the effects of ExMI on patients with PPI after robotic-assisted radical prostatectomy (RARP), specifically regarding health-related quality of life. From September to December 2014, patients with post-RARP PPI were enrolled in the study. A 20-minute ExMI treatment session was provided twice a week for two months. Number of voids, incontinence and urgency episodes, and mean and maximum voided volume per micturition (mL) were recorded in a 3-day bladder diary. Quality of life was assessed using the Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), and International Prostate Symptom Score quality-of-life questionnaire (IPSS-QoL). All assessments were conducted before and within 2 weeks after ExMI treatment. A favorable outcome was defined as an IPSS-QoL score 2-point decrease in the pretreatment score. Thirteen patients with a mean age of 69.3 years were enrolled. After ExMI, the number of incontinence episodes/3 d decreased to 5.85 from 9.15 (p = 0.004). The mean number of voids/d also decreased to 9.17 from 10.45 (p = 0.036). Patients' functional bladder capacity increased from 243.46 to 289.23 (p = 0.007). Scores of both UDI-6 and IPSS-QoL improved from 7.15 to 5.31 (p = 0.024) and 4.00 to 2.77 (p = 0.007). Patients aged
ISSN:1879-5226
DOI:10.1016/j.urols.2015.06.286